Search results for "staging"

showing 10 items of 740 documents

Impact of resection margin status and revision transoral laser microsurgery in early glottic cancer: analysis of organ preservation and local disease…

2022

Abstract Introduction Transoral laser microsurgery represents the treatment of choice for early glottic cancer. Its use and effectiveness are mainly related to laryngeal exposure and deep extension of tumor. Histopathologic assessment of surgical margin presents a main issue about transoral laser microsurgery and complete oncological excision. Objective The aim was to analyze the impact of revision surgery on organ preservation and local disease control in patients with early glottic cancer treated by transoral laser microsurgery. Methods We carried out a retrospective study on a cohort of 153 patients with early glottic cancer (Tis, T1, T2) treated by transoral laser microsurgery. Resectio…

Laser surgeryGlottisMicrosurgerymedicine.medical_specialtySurgical marginLaser surgerymedicine.medical_treatment03 medical and health sciences0302 clinical medicineLaryngeal cancerSquamous cell carcinomamedicineCarcinomaHumansTransoral laser microsurgery030223 otorhinolaryngologyLaryngeal NeoplasmsNeoplasm StagingRetrospective StudiesCarcinoma espinocelularbusiness.industryCarcinomaMargins of ExcisionRetrospective cohort studyOrgan PreservationCarbon Dioxidemedicine.diseaseTongue NeoplasmsSurgerySettore MED/31 - OtorinolaringoiatriaOtorhinolaryngologyGlottic cancer030220 oncology & carcinogenesisCohortResection marginCâncer de laringeCirurgia a laserLaser TherapybusinessBrazilian Journal of Otorhinolaryngology
researchProduct

Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer.

2007

Signaling mediating colorectal cancer (CRC) progression is incompletely understood. Previously, we identified lipopolysaccharide (LPS), an endotoxin of ubiquitously existing colonic bacteria, as a pivotal stimulus increasing the metastatic potential of human CRC. Since the ubiquitous colonic bacteria release large amounts of LPS this observation could be of enormous relevance for the progression of CRC. In this study we present data contributing to the elucidation of its mode of action. Since both receptors CD14 and TLR4 act as LPS mediators, we determined their expression in various CRC cell lines and in 115 non-metastatic, lymphogenous-metastatic and haematogenous-metastatic CRC specimens…

LipopolysaccharidesColorectal cancerCellLipopolysaccharide ReceptorsBiologyDownregulation and upregulationCell Line TumorGeneticsmedicineHumansNeoplasm MetastasisReceptorFluorescent Antibody Technique IndirectNeoplasm StagingRetrospective StudiesOncogeneCarcinomaGeneral MedicineCell cyclemedicine.diseaseMolecular medicineImmunohistochemistrydigestive system diseasesGene Expression Regulation NeoplasticToll-Like Receptor 4medicine.anatomical_structureLymphatic MetastasisImmunologyTLR4Cancer researchlipids (amino acids peptides and proteins)Caco-2 CellsColorectal NeoplasmsInternational journal of molecular medicine
researchProduct

Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma

2003

With the widespread use of ultrasonography (US) and computerized tomography (CT), the usefulness of α-fetoprotein assay in the diagnosis of hepatocellular carcinoma (HCC) has decreased. The aim of our study was to evaluate the best cut-off value for serum α-fetoprotein to discriminate between liver cirrhosis (LC) and HCC and the factors influencing levels in a Sicilian population. Three hundred and seventy-two patients with LC and 197 with HCC-associated LC were studied. The etiology was: HCV in 288 cases (77.4%) of LC and 147 cases (75%) of HCC; HBV in 31 cases (8.3%) of LC and 15 cases (7.6%) of HCC; HCV/HBV in 21 cases (5.6%) of LC and 6 cases (3.0%) of HCC; non-viral in 32 cases (8.6%) …

Liver CirrhosisMaleCancer ResearchCarcinoma HepatocellularHepatocellular carcinomaMedicine (all)Liver NeoplasmsMiddle AgedLiver cirrhosiDiagnosis DifferentialOncologyROC CurveArea Under CurveUltrasoundHumansRegression AnalysisFemalealpha-Fetoproteinsα-FetoproteinDiagnosiAgedNeoplasm StagingRetrospective Studies
researchProduct

Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.

2005

Background & Aims: Transcatheter arterial chemoembolization (TACE) currently is used as a palliative treatment for patients with unresectable hepatocellular carcinoma (HCC), but its efficacy still is debated. Our aim was to assess the impact of TACE on patient survival and to identify prognostic factors for survival. Methods: Fifty-six cirrhotic patients with unresectable HCC undergoing at least :1 course of TACE were matched 1:1. for sex, age (in 5-year periods), parameters of Child-Pugh score, Okuda stage, and tumor type with a control group who had received only supportive care. Results: The 2 groups were comparable for cause of cirrhosis, alpha-fetoprotein serum levels, and Cancer of th…

Liver CirrhosisMaleCirrhosisTime FactorsPrognostic systemGastroenterologyOily chemoembolizationHepatic ArteryCause of DeathAscitesValidationMedicineStage (cooking)CIRRHOSISUnivariate analysisAntibiotics AntineoplasticLiver NeoplasmsGastroenterologyLiver-TransplantationMiddle AgedHEPATOCELLULAR CARCINOMA; CIRRHOSIS; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; SURVIVAL; SIDE EFFECTSPrognosisTreatment OutcomeItalyRandomized controlled trialHepatocellular carcinomaSURVIVALFemalemedicine.symptommedicine.medical_specialtyCarcinoma HepatocellularMultivariate-analysiTransarterial chemoembolizationInternal medicineSIDE EFFECTSCarcinomaHumansHEPATOCELLULAR CARCINOMAChemoembolization TherapeuticTranscatheter arterial chemoembolizationSurvival analysisAgedEpirubicinNeoplasm StagingCirrhosiHepatologybusiness.industrymedicine.diseaseSurvival AnalysisSurgeryLipiodol chemoembolizationTRANSCATHETER ARTERIAL CHEMOEMBOLIZATIONCase-Control StudiesMultivariate AnalysisbusinessFollow-Up StudiesClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct

SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C

2009

The staging of liver fibrosis is pivotal for defining the prognosis and indications for therapy in hepatitis C. Although liver biopsy remains the gold standard, several noninvasive methods are under evaluation for clinical use. The aim of this study was to validate the recently described sequential algorithm for fibrosis evaluation (SAFE) biopsy, which detects significant fibrosis (≥F2 by METAVIR) and cirrhosis (F4) by combining the AST-to-platelet ratio index and Fibrotest-Fibrosure, thereby limiting liver biopsy to cases not adequately classifiable by noninvasive markers. Hepatitis C virus (HCV) patients (2035) were enrolled in nine locations in Europe and the United States. The diagnosti…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosisBiopsyGastroenterologyFibrosisInternal medicineBiopsymedicineHumansLiver biopsy chronic hepatitia CNeoplasm StagingRetrospective StudiesHepatitisSettore MED/12 - GastroenterologiaHepatologymedicine.diagnostic_testbusiness.industryHepatitis CHepatitis C ChronicMiddle AgedHepatologymedicine.diseaseLiver biopsyFemaleHepatic fibrosisbusinessAlgorithmsHepatology
researchProduct

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

2020

© 2020 The Author(s).

Liver CirrhosisPROGNOSISCirrhosisSCORING SYSTEM[SDV]Life Sciences [q-bio]PROGRESSIONDiseaseBiomarker Cirrhosis NAFLD NASHSTEATOHEPATITISDEFINITIONSCohort Studies0302 clinical medicineNon-alcoholic Fatty Liver DiseaseNonalcoholic fatty liver diseasePharmacology (medical)030212 general & internal medicineLongitudinal StudiesRegistriesComputingMilieux_MISCELLANEOUSmedia_commonPharmacology. TherapyFatty liverLiver NeoplasmsNASHGeneral Medicine3. Good healthCirrhosisLiver317 PharmacyCohort0305 other medical scienceCohort studymedicine.medical_specialtySettore MED/12 - GASTROENTEROLOGIAGeriatrikQUESTIONNAIRENAFLD; NASH; Cirrhosis; Biomarker610 Medicine & health03 medical and health sciencesNAFLDmedicineSTEATOSISmedia_common.cataloged_instanceHumansALGORITHMEuropean unionIntensive care medicine030505 public healthbusiness.industryCONSUMPTIONBiomarkerSTAGING SYSTEMmedicine.diseaseDiabetes Mellitus Type 2Geriatrics3121 General medicine internal medicine and other clinical medicine3111 BiomedicineHuman medicineSteatohepatitisbusinessBiomarker; Cirrhosis; NAFLD; NASH
researchProduct

Contrast-enhanced MRI of the lung

2000

The lung has long been neglected by MR imaging. This is due to unique intrinsic difficulties: (1) signal loss due to cardiac pulsation and respiration; (2) susceptibility artifacts caused by multiple air-tissue interfaces; (3) low proton density. There are many MR strategies to overcome these problems. They consist of breath-hold imaging, respiratory and cardiac gating procedures, use of short repetition and echo times, increase of the relaxivity of existing spins by administration of intravenous contrast agents, and enrichment of spin density by hyperpolarized noble gases or oxygen. Improvements in scanner performance and frequent use of contrast media have increased the interest in MR ima…

Lung DiseasesMalemedicine.medical_specialtyLung NeoplasmsContrast MediaPerfusion scanningSensitivity and SpecificityVentilation/perfusion ratiomedicineHumansRadiology Nuclear Medicine and imagingVascular DiseasesNeoplasm StagingLungbusiness.industryRespiratory diseaseInterstitial lung diseaseGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingPulmonary embolismContrast mediumCarcinoma Bronchogenicmedicine.anatomical_structureBreathingFemaleRadiologyPulmonary EmbolismPulmonary VentilationbusinessMagnetic Resonance AngiographyEuropean Journal of Radiology
researchProduct

Strategies to develop radiomics and machine learning models for lung cancer stage and histology prediction using small data samples

2021

Abstract Predictive models based on radiomics and machine-learning (ML) need large and annotated datasets for training, often difficult to collect. We designed an operative pipeline for model training to exploit data already available to the scientific community. The aim of this work was to explore the capability of radiomic features in predicting tumor histology and stage in patients with non-small cell lung cancer (NSCLC). We analyzed the radiotherapy planning thoracic CT scans of a proprietary sample of 47 subjects (L-RT) and integrated this dataset with a publicly available set of 130 patients from the MAASTRO NSCLC collection (Lung1). We implemented intra- and inter-sample cross-valida…

Lung NeoplasmsComputer scienceBiophysicsGeneral Physics and AstronomySample (statistics)Cross validationMachine learningcomputer.software_genreCross validation; Machine learning; Non-small cell lung cancer; Radiomics; Humans; Lung; Machine Learning; Neoplasm Staging; Carcinoma Non-Small-Cell Lung; Lung NeoplasmsCross-validationSet (abstract data type)Machine LearningNon-small cell lung cancerCarcinoma Non-Small-Cell LungmedicineHumansRadiology Nuclear Medicine and imagingStage (cooking)Lung cancerNon-Small-Cell LungLungNeoplasm StagingSmall dataRadiomicsbusiness.industryCarcinomaGeneral Medicinemedicine.diseaseRandom forestSupport vector machineArtificial intelligencebusinesscomputer
researchProduct

Standardisierte pathoanatomische Befunddokumentation auf den ADT-Tumorb�gen f�r Malignome des Mundes, der Kiefer und des Gesichts (Version III)

1995

The documentation form for pathohistologic findings (version III) for tumors of the maxillofacial region is presented. It is part of the site-specific documentation of the German Association of Tumor Centers (ADT). Its handling is explained by instructions which are based on the ICD-O classification and the TNM system. The prognostic relevance of the standardized documentation has already been proven by various histomorphologic investigations concerning oral and oropharyngeal cancer. By means of a multicentric observational study the German Austrian Swiss co-operative group DOSAK will develop a new prognostic model for oral and oropharyngeal cancer.

Lymphatic metastasismedicine.medical_specialtyPathologybusiness.industryGeneral surgeryMEDLINECancermedicine.diseaselanguage.human_languagePathology and Forensic MedicineGermanDocumentationlanguagePrognostic modelMedicineNeoplasm stagingObservational studybusinessDer Pathologe
researchProduct

Factors Associated With Fatigue After Surgery in Women With Early-Stage Invasive Breast Cancer

2013

Abstract Learning Objectives Describe the effect of worsening fatigue after breast cancer surgery on physical functioning and psychological distress. Better identify women at risk for developing cancer-related fatigue. Direct target interventions to patients most in need. Purpose. Fatigue is one of the most frequent symptoms in patients with cancer. However, the precise determinants of fatigue are still unknown. This study was conducted to investigate factors correlated with cancer-related fatigue before surgery and just before subsequent adjuvant therapy. Methods. Patients completed the Multidimensional Fatigue Inventory (MFI-20), the European Organization for Research and Treatment of Can…

MESH: FatigueCancer ResearchMultivariate analysisMESH: Lymph NodesDisease0302 clinical medicineMESH: Aged 80 and overQuality of lifeSurveys and Questionnaires030212 general & internal medicineNeoplasm Metastasisskin and connective tissue diseasesFatigueAged 80 and overMESH: AgedMESH: Middle AgedMESH: Neoplasm StagingMiddle Aged3. Good healthOncologySymptom Management and Supportive Care030220 oncology & carcinogenesisAnxietyMarital statusFemalemedicine.symptomAdultmedicine.medical_specialtyBreast Neoplasms03 medical and health sciencesBreast cancerAdjuvant therapymedicineHumansNeoplasm InvasivenessMESH: Surveys and QuestionnairesAgedNeoplasm StagingMESH: Humansbusiness.industryCancerMESH: Quality of LifeMESH: AdultMESH: Neoplasm Invasivenessmedicine.diseaseMESH: Neoplasm MetastasisSurgeryQuality of Life[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieLymph NodesbusinessMESH: FemaleMESH: Breast Neoplasms
researchProduct